Literature DB >> 24266403

Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions.

Yuichiro Aiba1, Jiaxin Hu, Jing Liu, Qin Xiang, Carlos Martinez, David R Corey.   

Abstract

Unlocked nucleic acid (UNA) is an acyclic analogue of RNA that can be introduced into RNA or DNA oligonucleotides. The increased flexibility conferred by the acyclic structure fundamentally affects the strength of base pairing, creating opportunities for improved applications and new insights into molecular recognition. Here we test how UNA substitutions affect allele-selective inhibition of expression of trinucleotide repeat genes Huntingtin (HTT) and Ataxin-3 (ATX-3). We find that the either the combination of mismatched bases and UNA substitutions or UNA substitutions alone can improve potency and selectivity. Inhibition is potent, and selectivities of >40-fold for inhibiting mutant versus wild-type expression can be achieved. Surprisingly, even though UNA preserves the potential for complete base pairing, the introduction of UNA substitutions at central positions within fully complementary duplexes leads to >19-fold selectivity. Like mismatched bases, the introduction of central UNA bases disrupts the potential for cleavage of substrate by argonaute 2 (AGO2) during gene silencing. UNA-substituted duplexes are as effective as other strategies for allele-selective silencing of trinucleotide repeat disease genes. Modulation of AGO2 activity by the introduction of UNA substitutions demonstrates that backbone flexibility is as important as base pairing for catalysis of fully complementary duplex substrates. UNA can be used to tailor RNA silencing for optimal properties and allele-selective action.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24266403      PMCID: PMC3893079          DOI: 10.1021/bi4014209

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

1.  Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.

Authors:  Dwaine A Braasch; Yinghui Liu; David R Corey
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Allele-specific silencing of dominant disease genes.

Authors:  Victor M Miller; Haibin Xia; Ginger L Marrs; Cynthia M Gouvion; Gloria Lee; Beverly L Davidson; Henry L Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

3.  Argonaute2 is the catalytic engine of mammalian RNAi.

Authors:  Jidong Liu; Michelle A Carmell; Fabiola V Rivas; Carolyn G Marsden; J Michael Thomson; Ji-Joon Song; Scott M Hammond; Leemor Joshua-Tor; Gregory J Hannon
Journal:  Science       Date:  2004-07-29       Impact factor: 47.728

Review 4.  Huntington's disease.

Authors:  Francis O Walker
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

Review 5.  Trinucleotide repeat disorders.

Authors:  Harry T Orr; Huda Y Zoghbi
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

6.  RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.

Authors:  Scott Q Harper; Patrick D Staber; Xiaohua He; Steven L Eliason; Inês H Martins; Qinwen Mao; Linda Yang; Robert M Kotin; Henry L Paulson; Beverly L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-05       Impact factor: 11.205

Review 7.  Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry L Paulson
Journal:  Semin Neurol       Date:  2007-04       Impact factor: 3.420

8.  Synthesis and evaluation of oligodeoxynucleotides containing acyclic nucleosides: introduction of three novel analogues and a summary.

Authors:  P Nielsen; L H Dreiøe; J Wengel
Journal:  Bioorg Med Chem       Date:  1995-01       Impact factor: 3.641

9.  Designing siRNA that distinguish between genes that differ by a single nucleotide.

Authors:  Dianne S Schwarz; Hongliu Ding; Lori Kennington; Jessica T Moore; Janell Schelter; Julja Burchard; Peter S Linsley; Neil Aronin; Zuoshang Xu; Phillip D Zamore
Journal:  PLoS Genet       Date:  2006-07-24       Impact factor: 5.917

10.  ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy.

Authors:  Jing Liu; Dongbo Yu; Yuichiro Aiba; Hannah Pendergraff; Eric E Swayze; Walt F Lima; Jiaxin Hu; Thazha P Prakash; David R Corey
Journal:  Nucleic Acids Res       Date:  2013-08-09       Impact factor: 16.971

View more
  13 in total

1.  Effect of 2'-O-methyl/thiophosphonoacetate-modified antisense oligonucleotides on huntingtin expression in patient-derived cells.

Authors:  Masayuki Matsui; Richard N Threlfall; Marvin H Caruthers; David R Corey
Journal:  Artif DNA PNA XNA       Date:  2014-12-15

Review 2.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

3.  Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Authors:  Mercedes Prudencio; Hector Garcia-Moreno; Karen R Jansen-West; Rana Hanna Al-Shaikh; Tania F Gendron; Michael G Heckman; Matthew R Spiegel; Yari Carlomagno; Lillian M Daughrity; Yuping Song; Judith A Dunmore; Natalie Byron; Björn Oskarsson; Katharine A Nicholson; Nathan P Staff; Sorina Gorcenco; Andreas Puschmann; João Lemos; Cristina Januário; Mark S LeDoux; Joseph H Friedman; James Polke; Robin Labrum; Vikram Shakkottai; Hayley S McLoughlin; Henry L Paulson; Takuya Konno; Osamu Onodera; Takeshi Ikeuchi; Mari Tada; Akiyoshi Kakita; John D Fryer; Christin Karremo; Inês Gomes; John N Caviness; Mark R Pittelkow; Jan Aasly; Ronald F Pfeiffer; Venka Veerappan; Eric R Eggenberger; William D Freeman; Josephine F Huang; Ryan J Uitti; Klaas J Wierenga; Iris V Marin Collazo; Philip W Tipton; Jay A van Gerpen; Marka van Blitterswijk; Guojun Bu; Zbigniew K Wszolek; Paola Giunti; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

4.  Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs.

Authors:  Jiaxin Hu; Jing Liu; Dongbo Yu; Yuichiro Aiba; Suheung Lee; Hannah Pendergraff; Jihane Boubaker; Jonathan W Artates; Clotilde Lagier-Tourenne; Walt F Lima; Eric E Swayze; Thazha P Prakash; David R Corey
Journal:  Nucleic Acid Ther       Date:  2014-04-02       Impact factor: 5.486

Review 5.  Oligonucleotide-based strategies to combat polyglutamine diseases.

Authors:  Agnieszka Fiszer; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2014-05-21       Impact factor: 16.971

6.  Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs.

Authors:  Jiaxin Hu; Jing Liu; K Jayaprakash Narayanannair; Jeremy G Lackey; Satya Kuchimanchi; Kallanthottathil G Rajeev; Muthiah Manoharan; Eric E Swayze; Walt F Lima; Thazha P Prakash; Qin Xiang; Carlos Martinez; David R Corey
Journal:  Biochemistry       Date:  2014-07-11       Impact factor: 3.162

7.  Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients.

Authors:  Niels H Skotte; Amber L Southwell; Michael E Østergaard; Jeffrey B Carroll; Simon C Warby; Crystal N Doty; Eugenia Petoukhov; Kuljeet Vaid; Holly Kordasiewicz; Andrew T Watt; Susan M Freier; Gene Hung; Punit P Seth; C Frank Bennett; Eric E Swayze; Michael R Hayden
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

8.  Mutant CAG Repeats Effectively Targeted by RNA Interference in SCA7 Cells.

Authors:  Agnieszka Fiszer; Joanna P Wroblewska; Bartosz M Nowak; Wlodzimierz J Krzyzosiak
Journal:  Genes (Basel)       Date:  2016-12-17       Impact factor: 4.096

9.  A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides.

Authors:  Dorota Magner; Ewa Biala; Jolanta Lisowiec-Wachnicka; Elzbieta Kierzek; Ryszard Kierzek
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

10.  Influence of mismatched and bulged nucleotides on SNP-preferential RNase H cleavage of RNA-antisense gapmer heteroduplexes.

Authors:  Dorota Magner; Ewa Biala; Jolanta Lisowiec-Wachnicka; Ryszard Kierzek
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.